Sun Pharmaceutical Industries Limited has completed the allotment of Non-Convertible Debentures (NCDs) on a private placement basis. This is a disclosure made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, further to an earlier communication dated 12 October 2026.
Nature of the Event
Allotment of rated, listed, unsecured, redeemable, non-convertible debentures (NCDs) on a private placement basis.
Key Quantitative Figures
- Aggregate Face Value Allotted: INR 7,816 crore
- Aggregate Issue Consideration: INR 7,816.02 crore
- Base Issue Size: INR 7,000 crore (fully subscribed)
- Greenshoe Option Exercised: INR 816 crore (out of a total available greenshoe option of up to INR 3,000 crore)
Series-wise Breakdown
Series A NCDs:
- Aggregate Face Value: INR 2,003 crore
- Number of Debentures: 2,00,300
- Face Value per Debenture: INR 1,00,000
- Issue Price: At par (INR 1,00,000 each)
- Coupon Rate: 8.05% per annum
Series B NCDs:
- Aggregate Face Value: INR 5,813 crore
- Part 1: 5,61,300 Debentures of face value INR 1,00,000 each, issued at par (INR 5,613 crore aggregate)
- Part 2: 20,000 Debentures of face value INR 1,00,000 each, issued at a premium of INR 10 per Debenture (INR 1,00,010 each), resulting in an aggregate face value of INR 200 crore and aggregate issue consideration of INR 200.02 crore
- Coupon Rate: 8.20% per annum
Dates of Action
- Deemed Date of Allotment: 26 October 2026
Tenure and Redemption Schedule
Tenor: 5 Years and 1 day from the Deemed Date of Allotment for both series.
Scheduled Redemption Date: 27 October 2031 for both series.
Series A Put Option: Holders have a put option exercisable on 27 March 2028.
Coupon Payment Schedule
Series A NCDs (Due Dates):
- 27 March 2027
- 27 March 2028
- 27 March 2029
- 27 March 2030
- 27 March 2031
- 27 October 2031 (final)
Series B NCDs (Due Dates):
- 27 October 2027
- 27 October 2028
- 27 October 2029
- 27 October 2030
- 27 October 2031 (final)
Coupon payments falling on a non-Business Day shall be made in accordance with the applicable Business Day Convention.
Principal Repayment
The Debentures shall be redeemed at par on the Scheduled Redemption Date (27 October 2031). Series A Debentures are also redeemable at par pursuant to the put option exercisable on 27 March 2028. The Debentures are also subject to mandatory redemption upon the occurrence of specified events as per the Key Information Document.
Security
The Debentures are unsecured and are not secured by any charge over the assets of the Company.
Listing
The NCDs are proposed to be listed on BSE Limited and the National Stock Exchange of India Limited.
Parties Involved
The disclosure was signed by Anoop Anjanikumar Deshpande, Company Secretary and Compliance Officer (ICSI Membership No.: A23983).